期刊文献+

银屑病关节炎患者抗核周因子的检测 被引量:2

Antiperinuclear factor in psoriatic arthritis
下载PDF
导出
摘要 目的 评价抗核周因子 (antiperinuclear factor,APF)在诊断、鉴别诊断银屑病关节炎与类风湿关节炎的作用。方法 以人颊黏膜上皮细胞为底物用间接免疫荧光法对 4 0例银屑病关节炎、6 4例寻常型银屑病、15 1例非炎症性风湿病、2 2 0例类风湿关节炎 (15 7例类风湿因子阳性 ,6 3例类风湿因子阴性 )的患者以及 176名健康对照者进行了血清 APF的检测。结果 银屑病关节炎患者 APF阳性率 7.5 % ,比健康对照者增高 (1.1% ,P<0 .0 5 ) ,与寻常型银屑病 (3.1% )和非炎症性风湿病 (3.3% )患者阳性率相似 ,差异无统计学意义 ,但低于类风湿因子阴性的类风湿关节炎患者 (5 4 .0 % ,P<0 .0 0 1)和类风湿因子阳性的类风湿关节炎患者 (83.4 % ,P<0 .0 0 1) ,3例 APF阳性的银屑病关节炎均为多关节炎累及 ,其类风湿因子阳性。结论  APF检测有助于银屑病关节炎和类风湿关节炎的鉴别和银屑病关节炎的分型。 Objective To evaluate whether antiperinuclear factor (APF) determination is useful for the diagnosis of psoriatic arthritis (PA).Methods APF in sera from patient with psoriatic arthropathy (PA,n=40),psoriasis vulgaris (n=64),noninflammatory rheumatic disease (NIRDs,n=151),rheumatoid arthritis (RA,n=220) both with negative (n=63) and positive (n=157) rheumatoid factor (RF) tests,as well as from 176 healthy controls was determined,using an indirect immunofluorescence test on epithelial cells from human buccal mucosa as a substrate.Results In patients with PA,7.5% of the serum samples were APF-positive.The incidence was greater than in healthy controls (1.1%,P<0.05),similar to that with uncomplicated psoriasis (3.1%,P=NS) and NIRDs (3.3%,P=NS),and lower than in RF-negative (54.0%,P<0.001) and RF-positive (83.4%,P<0.001) patients with RA.Three APF-positive patients with PA had symmetric joint involvement.Conclusion The APF test may be useful in differentiating PA from RA,and APF may be specific for symmetric polyarthritis.
出处 《山西医药杂志》 CAS 2004年第12期1009-1011,共3页 Shanxi Medical Journal
基金 山西省自然科学基金资助项目 (2 0 0 0 10 73) 太原市科委启明星资助项目 (10 10 2 0 2 6 )
关键词 银屑病 类风湿关节炎 类风湿因子 阳性率 关节炎患者 抗核周因子 APF 底物 上皮细胞 Arthritis,psoriatic Antiperinuclear factor Arthritis,rheumatoid
  • 相关文献

参考文献9

  • 1[1]Girbal-Neuhauser E,Montezlin M,Croute F,et al.Normal human epidermal keratinocytes express in vitro specific molecular forms of (pro) filaggrin recognized by rheumatoid arthritis-associated antifilaggrin autoantibodies.Mol Med,1997,3:145-156.
  • 2[2]Moll JM,Wright V.Psoriatic arthritis.Semin Arthritis Rheum,1973,3:55-78.
  • 3[3]Ruzicka T.Psoriatic arthritis:new types,new treatments.Arch Dermatol,1996,132:215-219.
  • 4[4]Arnett FC,Edworthy SM,Bloch DA,et al.The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis Rheum,1988,31:315-324.
  • 5李小峰,张乃峥,李鸿斌,甘晓丹,唐福林,董怡,崔京涛,张帆.类风湿关节炎血清学早期诊断[J].中华风湿病学杂志,1999,3(4):208-211. 被引量:57
  • 6[6]Sennett RM.Psoriatic arthritis.In:McCarty DJ,Koopman WJ,eds.Arthritis and Allied Conditions.12th ed.Philadelphia:Lea & Febiger,1992.1079-1094.
  • 7[7]Gladman DD,Shuckett R,Russell ML,et al.Psoriatic arthritis:an analysis of 220 patients.Q J Med,1987,62:127-141.
  • 8[8]Calzavara-Pinton PG,Franceschini F,Manera C,et al.Antiperinuclear factor in psoriatic arthropathy.J Am Acad Dermatol,1999,40:910-913.
  • 9钱龙,曾庆馀,黄少弼,肖征宇,许杰洲,谢素和.抗核周因子的检测及其在类风湿关节炎中的意义[J].中华风湿病学杂志,1999,3(2):100-103. 被引量:29

共引文献78

同被引文献27

  • 1Schellekens GA, Visser H, De-Jong BAW, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum, 2000, 43: 155-163.
  • 2Schellekens GA, Visser H, de Jong BAW, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum, 2000, 43: 155-163.
  • 3Bogliolo L, Alpini C, Caporali R, et al, Antibodies to cyclic citrullinated peptides in psoriatic arthritis.J Rheumatol, 2005, 32: 511-515.
  • 4Alenius GM, Berglin E, Rantapaa-Dahlqvist S. Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation. Ann Rheum Dis, 2006, 65: 398-400.
  • 5Korendowych E, Owen P, Ravindran J, et al. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis. Rheumatology (Oxford), 2005, 44: 1056-1060.
  • 6Van der-Cruyssen B, Hoffman IEA, Zmierczak H, et al. Anticitrullinated peptide antibodies may occur in patients with psoriatic arthritis. Ann Rheum Dis, 2005, 64:1145-1149.
  • 7Inanc N, Dalkilic E, Kamali S, et al. Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis. Clin Rheumatol, 2007, 26: 17-23.
  • 8Bizzaro N, Mazzanti G, Tonutti E, et al. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem, 2001, 47: 1089-1093.
  • 9Moll JMH, Wright V. Psoriatic arthritis. Semin Arthritis Rheum, 1973, 3: 55-78.
  • 10Bennett RM. Psoriatic arthritis// MeCarty DJ. Arthritis and Related Conditions. Philadelphia: Lea Febiger, 1979: 645.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部